Developing a new AI framework for better cancer treatment imaging
A Fully Decentralized Federated Learning Framework for Automated Image Segmentation in Cancer Radiotherapy
This study is working on a new way to use artificial intelligence to help doctors better identify organs in CT scans for patients with liver and head and neck cancers who are getting radiation therapy, all while keeping your personal information safe and secure.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10831775 on NIH RePORTER |
What this research studies
This research focuses on creating an innovative decentralized framework that utilizes artificial intelligence to improve the accuracy of image segmentation in cancer radiotherapy. By allowing different institutions to train AI models on their local data without sharing sensitive patient information, the approach aims to enhance the generalization capabilities of these models across diverse clinical environments. The framework will specifically target automated organ segmentation in CT images for patients with liver and head and neck cancers undergoing radiation therapy, addressing a critical challenge in accurately delineating organs at risk during treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with liver or head and neck cancers who are undergoing radiation therapy.
Not a fit: Patients with cancers not involving the liver or head and neck, or those not receiving radiation therapy, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective radiation therapy for cancer patients, improving treatment outcomes.
How similar studies have performed: Other research has shown promise in using decentralized AI approaches for medical imaging, indicating potential success for this novel method.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Yuan, Yading — Columbia University Health Sciences
- Study coordinator: Yuan, Yading
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.